BIT:1IOVA • US4622601007
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI).
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.189M | 164.07M 13,698.99% | 263.502M 60.60% | 389.29M 47.74% | 546.21M 40.31% | 774.62M 41.82% | 801.96M 3.53% | 889.51M 10.92% | 734.91M -17.38% | 851.68M 15.89% | 984.38M 15.58% | |
| EBITDA YoY % growth | -439.142M -12.72% | -354.709M 19.23% | -362.274M -2.13% | -210.599M 41.87% | -118.079M 43.93% | -3.499M 97.04% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -460.559M -15.46% | -387.878M 15.78% | -398.213M -2.66% | -229.755M 42.30% | -122.186M 46.82% | 944.928K 100.77% | 42.225M 4,368.59% | 92.124M 118.17% | 28.382M -69.19% | 69.972M 146.54% | 127.28M 81.90% | |
| Operating Margin | -38,734.99% | -236.41% | -151.12% | -59.02% | -22.37% | 0.12% | 5.27% | 10.36% | 3.86% | 8.22% | 12.93% | |
| EPS YoY % growth | -1.88 24.19% | -1.30 30.85% | -1.12 13.85% | -0.50 55.58% | -0.22 55.49% | 0.03 114.59% | 0.17 421.00% | 0.38 126.24% | 0.41 7.15% | 0.41 | 0.41 |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 59.77% | -0.13 60.26% | -0.12 52.49% | -0.12 34.41% | -0.08 46.48% | -0.06 53.33% | -0.03 71.66% | -0.01 93.37% |
| Revenue Q2Q % growth | 83.742M 69.78% | 92.624M 54.50% | 101.84M 50.97% | 110.33M 27.15% | 132.4M 58.10% | 141.07M 52.30% | 149.74M 47.03% | 158.41M 43.58% |
| EBITDA Q2Q % growth | -53.402M 52.75% | -50.102M 48.09% | -46.543M 26.99% | -46.813M -24.76% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -68.005M 43.90% | -61.316M 46.11% | -55.437M 38.24% | -47.395M 35.48% | -25.602M 62.35% | -19.584M 68.06% | -13.26M 76.08% | -6.63M 86.01% |
All data in USD
17 analysts have analysed 1IOVA.MI and the average price target is 7.95 EUR. This implies a price increase of 156.75% is expected in the next year compared to the current price of 3.095.
IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI) is -0.14 EUR and the consensus revenue estimate is 83.74M EUR.
The consensus rating for IOVANCE BIOTHERAPEUTICS INC (1IOVA.MI) is 78.8235 / 100 . This indicates that analysts generally have a positive outlook on the stock.